A5025304485- Antiplatelet Therapy and Cardiovascular Diseases
- Coronary Interventions and Diagnostics
- Lipoproteins and Cardiovascular Health
- Diabetes Treatment and Management
- COVID-19 Clinical Research Studies
- Atrial Fibrillation Management and Outcomes
- SARS-CoV-2 and COVID-19 Research
- Long-Term Effects of COVID-19
- vaccines and immunoinformatics approaches
- Graphene and Nanomaterials Applications
- Nuclear Receptors and Signaling
- Ginkgo biloba and Cashew Applications
- Pharmaceutical Economics and Policy
- Inflammatory mediators and NSAID effects
- Parkinson's Disease Mechanisms and Treatments
- Diet, Metabolism, and Disease
- Microbial Natural Products and Biosynthesis
- Nanoparticles: synthesis and applications
- Metabolism, Diabetes, and Cancer
- Liver Disease Diagnosis and Treatment
- Computational Drug Discovery Methods
- Advanced Photocatalysis Techniques
Daffodil International University
2022-2025
Dhaka International University
2023
University of Rajshahi
2020-2022
The most effective antiplatelet treatments for acute coronary syndrome (ACS) patients carrying CYP2C19 loss-of-function (LoF) alleles undergoing percutaneous intervention (PCI) is still debating and conflicting. It was aimed to compare the efficacy safety endpoints these treated with alternative P2Y12 receptor blockers (e.g. prasugrel or ticagrelor) against clopidogrel. Literature searched in PubMed, Cochrane library, Synapse 1000 Genomes databases following PRISMA guidelines identifying...